Beneficient Form 8-K Summary
Business Context and Reporting Period
Beneficient filed a Current Report on Form 8-K covering events beginning March 22, 2024. The filing addresses Nasdaq listing compliance, unregistered equity issuances, and the designation of Series B-4 Resettable Convertible Preferred Stock. The report was signed on March 28, 2024.
Financial Metrics and Capitalization
The filing does not provide revenue, profit, cash flow, margin, debt, liquidity, or other operating financial metrics.
- On March 27, 2024, the Company issued 6,932 shares of Series B-4 Preferred Stock to a consultant for business advisory services.
- The preferred stock initially converts at $0.0673 per Class A common share, subject to monthly resets and a floor price of $0.03365.
- Up to 2,060,030 Class A common shares may be issued upon conversion of the Series B-4 Preferred Stock.
- On March 26, 2024, the Company issued 3,920,208 shares of Class A common stock to a consultant for customer referral services.
- Both issuances were unregistered and made in reliance on Section 4(a)(2) and Regulation D exemptions.
Material Changes Versus the Prior Comparable Period
- Nasdaq determined that the Class A common stock had a closing bid price of $0.10 or less for at least ten consecutive trading days as of March 21, 2024.
- Nasdaq issued a Staff Determination to delist the Company’s securities unless the Company timely requests a hearing.
- The Company intends to appeal. The appeal automatically stays delisting at least through completion of the hearing process, so the Class A common stock and warrants remain listed pending the process.
- Stockholders approved a potential 1-for-10 to 1-for-100 reverse stock split, with the exact ratio to be determined by the Board, if implemented.
Outlook, Risks, Contingencies, and Unusual Items
- Management is evaluating measures to regain compliance with Nasdaq’s Bid Price Rule and Low Priced Stocks Rule, including a possible reverse stock split.
- There is no assurance that the Nasdaq Hearings Panel will approve the Company’s plan, grant continued listing, or provide an additional compliance period.
- There is no assurance that a reverse stock split would restore compliance or preserve the Nasdaq listing.
- Series B-4 Preferred Stock ranks senior to the common stock, pari passu with specified existing preferred stock series, and junior to all indebtedness with respect to liquidation and dividend rights.
- Series B-4 Preferred Stock has a $10.00 per-share liquidation preference, receives dividends only when and if paid on an as-converted basis to Class A common stock, and generally has no voting rights.
- Conversions are subject to a 4.99% beneficial ownership limitation and may be delayed if the limitation would be exceeded.
- The filing identifies risks involving Nasdaq compliance, potential reverse-stock-split effects, costs and management distraction, and other risks disclosed in the Company’s SEC filings.
Important Facts Investors Should Verify
- Whether Beneficient timely requested and completed the Nasdaq Hearings Panel process and the resulting listing decision.
- Whether the Board implemented a reverse stock split, including the final ratio and effective date.
- The actual number of Class A shares outstanding after the vendor issuances and any Series B-4 conversions.
- Future monthly resets of the Series B-4 conversion price and the resulting potential dilution.
- The terms and outstanding amounts of the Company’s other preferred stock and debt obligations.
- Subsequent SEC filings for updated financial statements, liquidity information, operating results, and risk disclosures.